1. Home
  2. TRNS vs FTRE Comparison

TRNS vs FTRE Comparison

Compare TRNS & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRNS
  • FTRE
  • Stock Information
  • Founded
  • TRNS 1964
  • FTRE 1996
  • Country
  • TRNS United States
  • FTRE United States
  • Employees
  • TRNS N/A
  • FTRE N/A
  • Industry
  • TRNS Electrical Products
  • FTRE Medical Specialities
  • Sector
  • TRNS Industrials
  • FTRE Health Care
  • Exchange
  • TRNS Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • TRNS 842.7M
  • FTRE 701.9M
  • IPO Year
  • TRNS N/A
  • FTRE N/A
  • Fundamental
  • Price
  • TRNS $72.61
  • FTRE $10.31
  • Analyst Decision
  • TRNS Buy
  • FTRE Hold
  • Analyst Count
  • TRNS 4
  • FTRE 9
  • Target Price
  • TRNS $108.67
  • FTRE $12.06
  • AVG Volume (30 Days)
  • TRNS 115.1K
  • FTRE 1.9M
  • Earning Date
  • TRNS 10-27-2025
  • FTRE 11-07-2025
  • Dividend Yield
  • TRNS N/A
  • FTRE N/A
  • EPS Growth
  • TRNS N/A
  • FTRE N/A
  • EPS
  • TRNS 1.44
  • FTRE N/A
  • Revenue
  • TRNS $288,138,000.00
  • FTRE $2,733,500,000.00
  • Revenue This Year
  • TRNS $16.67
  • FTRE N/A
  • Revenue Next Year
  • TRNS $9.14
  • FTRE N/A
  • P/E Ratio
  • TRNS $50.20
  • FTRE N/A
  • Revenue Growth
  • TRNS 8.49
  • FTRE N/A
  • 52 Week Low
  • TRNS $67.56
  • FTRE $3.97
  • 52 Week High
  • TRNS $133.72
  • FTRE $25.28
  • Technical
  • Relative Strength Index (RSI)
  • TRNS 35.50
  • FTRE 62.95
  • Support Level
  • TRNS $75.30
  • FTRE $9.82
  • Resistance Level
  • TRNS $79.89
  • FTRE $10.57
  • Average True Range (ATR)
  • TRNS 3.12
  • FTRE 0.67
  • MACD
  • TRNS -1.05
  • FTRE -0.12
  • Stochastic Oscillator
  • TRNS 10.05
  • FTRE 43.58

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: